Annual EBITDA
-$2.86B$897.00M+23.88%
Summary
- Current Value
- As of today, MRNA annual EBITDA is -$2.86B, up +23.88% on
- Historical Performance
- MRNA annual EBITDA is down -129.74% over the past 3 years, down -290.63% over the past 5 years
- All-Time High Comparison
- MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on
- 3-Year Low Comparison
- MRNA annual EBITDA is +23.88% above its 3-year low of -$3.76B reached on
- Sector Comparison
- MRNA annual EBITDA is higher than 0.18% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$2.86B | +23.9% | -129.7% | -290.6% | -10000.0% | |
| Quarterly EBITDA | -$752.00M | +11.5% | +57.7% | -124.0% | -10000.0% | |
| TTM EBITDA | -$3.08B | -0.5% | -498.8% | -178.6% | -10000.0% | |
| Price | $60.57 | +137.8% | -40.3% | -84.3% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $1.94B | -39.9% | -89.8% | +142.0% | +10000.0% | |
| Annual EPS | -$7.25 | +21.8% | -136.1% | -270.3% | +99.8% | |
| $0.00 | +100.0% | -100.0% | +100.0% | +100.0% | ||
| Annual Net Income | -$2.82B | +20.8% | -133.8% | -277.8% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.61B | N/A | -129.7% |
| 5Y | $13.47B | -121.2% | |
| All | $13.47B | -121.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.76B | +23.9% | |
| 5Y | -$3.76B | +23.9% | |
| All | -$3.76B | +23.9% |
EBITDA History
FAQ
- What is the current annual EBITDA of MRNA?
- As of today, MRNA annual EBITDA is -$2.86B
- What is 1-year change in MRNA annual EBITDA?
- MRNA annual EBITDA is up +23.88% year-over-year
- What is 3-year change in MRNA annual EBITDA?
- MRNA annual EBITDA is down -129.74% over the past 3 years
- How far is MRNA annual EBITDA from its all-time high?
- MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on December 31, 2021
- How does MRNA annual EBITDA rank versus sector peers?
- MRNA annual EBITDA is higher than 0.18% of companies in Healthcare sector
- When is MRNA next annual earnings release?
- As of today, the next annual earnings release for MRNA has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$752.00M$577.00M+43.42%
Summary
- Current Value
- As of today, MRNA quarterly EBITDA is -$752.00M, up +43.42% on
- Historical Performance
- MRNA quarterly EBITDA is up +11.53% year-over-year, up +57.68% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EBITDA is currently -113.88% below its historical high of $5.42B set on
- 3-Year Low Comparison
- MRNA quarterly EBITDA is +57.68% above its 3-year low of -$1.78B reached on an earlier date
- Sector Comparison
- MRNA quarterly EBITDA is higher than 0.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$752.00M | +43.4% | +11.5% | +57.7% | -124.0% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| TTM EBITDA | -$3.08B | +3.1% | -0.5% | -498.8% | -178.6% | |
| Price | $60.57 | +14.5% | +137.8% | -40.3% | -84.3% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $145.00M | -62.7% | +2.1% | -57.9% | -96.7% | |
| Quarterly EPS | -$1.96 | +42.2% | +7.6% | +45.8% | -130.5% | |
| -$815.00M | +41.3% | +10.1% | +56.4% | -126.6% | ||
| Quarterly Net Income | -$782.00M | +41.8% | +5.2% | +43.3% | -128.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$208.00M | -261.5% | |
| 3Y | $200.00M | -476.0% | |
| 5Y | $5.42B | -113.9% | |
| All | $5.42B | -113.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.33B | +43.4% | |
| 3Y | -$1.78B | N/A | +57.7% |
| 5Y | -$1.78B | +57.7% | |
| All | -$1.78B | +57.7% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of MRNA?
- As of today, MRNA quarterly EBITDA is -$752.00M
- What is MRNA quarterly EBITDA most recent change?
- MRNA quarterly EBITDA was up +43.42% on June 30, 2026
- What is 1-year change in MRNA quarterly EBITDA?
- MRNA quarterly EBITDA is up +11.53% year-over-year
- How far is MRNA quarterly EBITDA from its all-time high?
- MRNA quarterly EBITDA is currently -113.88% below its historical high of $5.42B set on December 31, 2021
- How does MRNA quarterly EBITDA rank versus sector peers?
- MRNA quarterly EBITDA is higher than 0.10% of companies in Healthcare sector
- When is MRNA next earnings release?
- The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$3.08B$98.00M+3.08%
Summary
- Current Value
- As of today, MRNA TTM EBITDA is -$3.08B, up +3.08% on
- Historical Performance
- MRNA TTM EBITDA is down -0.46% year-over-year, down -498.83% over the past 3 years
- All-Time High Comparison
- MRNA TTM EBITDA is currently -118.69% below its historical high of $16.47B set on
- 3-Year Low Comparison
- MRNA TTM EBITDA is +32.63% above its 3-year low of -$4.57B reached on
- Sector Comparison
- MRNA TTM EBITDA is higher than 0.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$3.08B | +3.1% | -0.5% | -498.8% | -178.6% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| Quarterly EBITDA | -$752.00M | +43.4% | +11.5% | +57.7% | -124.0% | |
| Price | $60.57 | +14.5% | +137.8% | -40.3% | -84.3% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.23B | +0.1% | -27.6% | -78.9% | -68.3% | |
| TTM EPS | -$7.98 | +2.0% | -6.2% | -393.3% | -199.7% | |
| -$3.32B | +2.7% | -1.4% | -907.8% | -187.0% | ||
| TTM Net Income | -$3.15B | +1.4% | -8.5% | -361.1% | -190.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.86B | -7.7% | |
| 3Y | $772.00M | N/A | -498.8% |
| 5Y | $16.47B | -118.7% | |
| All | $16.47B | -118.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.26B | +5.4% | |
| 3Y | -$4.57B | +32.6% | |
| 5Y | -$4.57B | +32.6% | |
| All | -$4.57B | +32.6% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of MRNA?
- As of today, MRNA TTM EBITDA is -$3.08B
- What is MRNA TTM EBITDA most recent change?
- MRNA TTM EBITDA was up +3.08% on June 30, 2026
- What is 1-year change in MRNA TTM EBITDA?
- MRNA TTM EBITDA is down -0.46% year-over-year
- How far is MRNA TTM EBITDA from its all-time high?
- MRNA TTM EBITDA is currently -118.69% below its historical high of $16.47B set on March 31, 2022
- How does MRNA TTM EBITDA rank versus sector peers?
- MRNA TTM EBITDA is higher than 0.19% of companies in Healthcare sector
- When is MRNA next earnings release?
- The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna